Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Dallas TX, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 6 - 29

Code: NCT04678427

Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Dallas TX, Austin TX, Denver CO, Chicago IL, Phoenix AZ,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase1, Recruiting

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm,
Location: Dallas TX, Duarte CA, The Bronx NY, Portland OR,
Sponsor: Eureka Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04864054

Phase1, Phase2, Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

for
Germ Cell Tumor
Location: Dallas TX, San Antonio TX, Corpus Christi TX,
Sponsor: University of Sydney

Sex: All

Age: 11 - 50

Code: NCT02582697

Phase3, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Dallas TX, Springdale AR, Denver CO, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Dallas TX, Denison TX, San Antonio TX, Cordova TN,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase3, Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Dallas TX, Houston TX, Denver CO, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase3, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Dallas TX, Oklahoma City OK, Houston TX, Tulsa OK,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

for
Pemphigus Vulgaris
Location: Dallas TX, Houston TX, Iowa City IA, Chicago IL,
Sponsor: Cabaletta Bio

Sex: All

Age: 18+

Code: NCT04422912

Phase1, Phase2, Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Dallas TX, McKinney TX, San Antonio TX, Houston TX,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase3, Recruiting

Trifecta-Lung cfDNA-MMDx Study

for
Lung Transplantation
Location: Dallas TX, San Antonio TX, Houston TX, Indianapolis IN,
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05837663

Recruiting

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

for
APOL1-Mediated Kidney Disease
Location: Dallas TX, Mesquite TX, Conroe TX, Shreveport LA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT06824987

Phase2, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Dallas TX, Austin TX, Houston TX, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Austin TX, Nashville TN, Louisville KY,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase1, Phase2, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: Dallas TX, Austin TX, Odessa TX, Columbia MO,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Dallas TX, Plano TX, Kansas City KS, Cordova TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Dallas TX, Topeka KS, Birmingham AL, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Lubbock TX, Jefferson LA, St Louis MO,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase3, Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: Dallas TX, Plano TX, Houston TX, Lake Charles LA,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

Observational Study Protocol: LIVER-R

for
Hepatobiliary Cancers
Location: Dallas TX, Temple TX, Baton Rouge LA, Osage Beach MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06252753

Recruiting